Riluzole
Back to searchMolecule Structure
Scientific Name
Riluzole
Description of the Drug
Riluzole is a glutamate antagonist used to treat amyotrophic lateral sclerosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00740
http://www.drugbank.ca/drugs/DB00740
Brand Name(s)
Exservan, Rilutek, Riluzole, Teglutik, Tiglutik kit
Company Owner(s)
Apotex Corp, Alkem Laboratories Ltd, Kenton Chemicals And Pharmaceuticals Corp, Covis Pharma Gmbh, Sun Pharmaceutical Industries Ltd, Daito Pharmaceuticals Co Ltd, Aquestive Therapeutics Inc, Italfarmaco Sa, Glenmark Pharmaceuticals Ltd, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL78905 | |||
PharmGKB | PA451251 | |||
Human Metabolome Database | HMDB0014878 | |||
DrugBank | DB00740 | |||
PubChem: Thomson Pharma | 14773880 | |||
PubChem | 5070 | |||
Mcule | MCULE-9362288181 | |||
LINCS | LSM-2471 | |||
Nikkaji | J22.921K | |||
PDBe | 657 | |||
BindingDB | 30705 | |||
EPA CompTox Dashboard | DTXSID3045192 | |||
DrugCentral | 2382 | |||
ChemicalBook | CB3353226 | |||
Guide to Pharmacology | 2326 | |||
rxnorm | RILUZOLE | EXSERVAN | RILUTEK | TIGLUTIK |
PubChem: Drugs of the Future | 12013649 | |||
KEGG Ligand | C07937 | |||
ChEBI | 8863 | |||
ZINC | ZINC000000006481 |